The disclosure provides methods and compositions for the treatment of vascular, autoimmune and inflammatory diseases using a combination of an inosine monophosphate dehydrogenase (IMPDH) inhibitor and a HMG CoA reductase inhibitor.

 
Web www.patentalert.com

< 70 human secreted proteins

< Benzamide modulators of metabotropic glutamate receptors

> Insulin secretion potentiator

> Indole-derivative modulators of steroid hormone nuclear receptors

~ 00297